Incremental value of the combined brain-cardiac CT protocol on prediction of atrial fibrillation after stroke.
Atrial fibrillation
CT scan
epicardial fat tissue
risk score
stroke
Journal
European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
02
09
2022
accepted:
21
10
2022
medline:
7
4
2023
entrez:
6
4
2023
pubmed:
7
4
2023
Statut:
ppublish
Résumé
Atrial fibrillation (AF) is one of the most common causes of ischemic stroke. It is essential to target patients at highest risk of AF detected after stroke (AFDAS), who should benefit from a prolonged rhythm screening strategy. Cardiac-CT angiography (CCTA) was added to the stroke protocol used in our institution in 2018. We sought to assess, for AFDAS, the predictive value of atrial cardiopathy markers by a CCTA performed on admission for acute ischemic stroke. From November 2018 to October 2019, consecutive stroke patients with no history of AF were included. Let atrial volume (LAV), epicardial adipose tissue (EAT) attenuation and volume, and LAA characteristics were measured on CCTA. The primary endpoint was the presence of AFDAS at follow-up, diagnosed by continuous electrocardiographic monitoring, long-term external Holter monitoring during hospital stay, or implantable cardiac monitor (ICM). Sixty of the 247 included patients developed AFDAS. Multivariable analysis shows independent predictors of AFDAS: age >80 years (HR 2.46; 95%CI (1.23-4.92), Adding CCTA to the acute stroke protocol to assess markers of atrial cardiopathy associated with AFDAS may help to better stratify the AF screening strategy, including the use of an ICM.
Identifiants
pubmed: 37021162
doi: 10.1177/23969873221138197
pii: 10.1177_23969873221138197
pmc: PMC10069180
doi:
Types de publication
Journal Article
Langues
eng
Pagination
175-182Informations de copyright
© European Stroke Organisation 2022.
Déclaration de conflit d'intérêts
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Int J Stroke. 2019 Feb;14(2):207-214
pubmed: 30196789
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E771-E780
pubmed: 28096344
Neurology. 2019 Jan 8;92(2):e115-e124
pubmed: 30530796
J Cardiovasc Imaging. 2018 Jun;26(2):65-74
pubmed: 29971268
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Medicine (Baltimore). 2016 Apr;95(14):e3260
pubmed: 27057876
Stroke. 2022 Mar;53(3):e94-e103
pubmed: 34986652
Neurology. 2022 Oct 4;99(14):e1456-e1464
pubmed: 35918169
Lancet Neurol. 2017 Apr;16(4):282-290
pubmed: 28187920
Lancet Neurol. 2015 Apr;14(4):377-87
pubmed: 25748102
Circ Arrhythm Electrophysiol. 2017 Feb;10(2):
pubmed: 28183844
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
J Stroke Cerebrovasc Dis. 2015 Oct;24(10):2263-9
pubmed: 26190307
Front Cardiovasc Med. 2022 Apr 29;9:888240
pubmed: 35571191
Medicine (Baltimore). 2016 Mar;95(11):e2874
pubmed: 26986099
Front Neurol. 2021 Mar 31;12:645822
pubmed: 33868150
Stroke. 2017 Feb;48(2):513-519
pubmed: 28077454
Stroke. 2015 Apr;46(4):936-41
pubmed: 25700289
Am J Cardiol. 2011 Dec 1;108(11):1680-5
pubmed: 21880291
Front Cardiovasc Med. 2022 Jul 13;9:949213
pubmed: 35911547
Acta Cardiol Sin. 2017 Jan;33(1):50-57
pubmed: 28115807
Int J Stroke. 2021 Aug;16(6):692-700
pubmed: 33143553
Diagnostics (Basel). 2021 Nov 11;11(11):
pubmed: 34829434
Europace. 2016 Oct;18(10):1455-1490
pubmed: 27402624
Eur Stroke J. 2022 Dec;7(4):487-495
pubmed: 36478762